Skip to main content

Table 1 Baseline patient characteristics before and after propensity score matching

From: Cost-effectiveness of polymyxin B hemoperfusion for septic shock: an observational study using a Japanese nationwide administrative database

 

Unmatched

Matched

PMX (n = 1492)

Control (n = 17,791)

ASD%

PMX (n = 965)

Control (n = 2895)

ASD%

Age, mean (SD)

72.7 (12.8)

77.2 (12.7)

35.1

72.9 (12.5)

73.9 (13.4)

0.2

Sex (male), n (%)

847 (46.8)

9792 (55.0)

13.6

548 (56.8)

1635 (56.5)

0.5

Emergency admission, n (%)

1336 (89.5)

17,196 (96.7)

25.3

883 (91.5)

2662 (92.0)

1.3

University hospital, n (%)

331 (22.2)

2130 (12.0)

23.3

186 (19.3)

565 (19.5)

0.5

ER/ICU admission, n (%)

1094 (73.3)

8237 (46.3)

45.9

670 (69.4)

2037 (70.4)

1.7

CCI, mean (SD)

1.9 (1.7)

1.9 (1.7)

1.6

1.9 (1.7)

2.0 (1.8)

1.3

CRRT, n (%)

950 (63.7)

1914 (10.8)

115.0

491 (50.9)

1418 (50.0)

1.5

HD, n (%)

71 (4.8)

734 (4.1)

2.5

59 (6.1)

160 (5.5)

2.0

Mechanical ventilation, n (%)

962 (64.5)

3901 (21.9)

79.6

528 (54.7)

1576 (54.4)

0.5

Surgery, n (%)

817 (57.8)

2443 (13.7)

89.8

418 (43.3)

1278 (44.2)

1.4

γ-globulin, n (%)

492 (33.9)

1313 (7.4)

60.5

242 (25.1)

672 (23.2)

3.6

rTM, n (%)

744 (49.9)

1604 (9.0)

89.8

356 (36.9)

960 (33.2)

6.4

AT III, n (%)

430 (28.8)

843 (4.7)

62.7

199 (20.6)

528 (18.2)

5.0

Steroid, n (%)

700 (46.9)

4614 (25.9)

37.3

428 (44.4)

1245 (43.0)

2.2

RBC transfusion, n (%)

572 (38.8)

2155 (12.1)

55.3

306 (31.7)

854 (29.5)

3.9

Platelet transfusion, n (%)

240 (16.1)

832 (4.7)

34.1

124 (12.9)

350 (12.1)

1.9

Maximum noradrenaline, mean (SD)

14.3 (12.9)

7.4 (9.9)

60.2

12.9 (11.6)

12.8 (13.1)

0.6

  1. ASD Absolute standard difference, SD Standard deviation, ER Emergency room, ICU Intensive care unit, CCI Charlson Comorbidity Index, CRRT Continuous renal replacement therapy, HD Hemodialysis, rTM recombinant thrombomodulin, AT Antithrombin, RBC Red blood cell